openPR Logo
Press release

Radionuclide Scanning Services Market is Expected to Witness a Steady Growth by 2017 – 2025

07-11-2017 10:19 AM CET | Health & Medicine

Press release from: Persistence Market Research

Radionuclide Scanning Services Market is Expected to Witness

Radionuclide scanning also called nuclear medicine imaging is the test that scans internal body parts with the use of radioactive material. This overcomes the limitations of standard X-Ray systems to reach and scan every body part. A radionuclide is used as a label to the substance that accumulates in specific part of the body such as Iodine is used to make thyroid hormones and thus accumulates in the thyroid glands similarly, Diphosphonate accumulates where bone is repairing or rebuilding itself. The tracer is swallowed, inhaled or injected under the skin which emits gamma rays, so the doctors can detect the location of tracer by the use of special scanners or cameras. Highly qualified personnel are required for this process.

Radionuclide scanning can be used to visualize images in 2D using Scintigraphy technique as well as in 3D representation using SPECT. Some of the commonly used radionuclides for the service include Iodine-131, Yttrium-90, Samarium-153, Fluorine-18 and many others.

Radionuclide Scanning Services Market: Drivers & Restraints

With the surge in the nuclear medicine imaging industry, the radionuclide scanning services market is also anticipated to increase during the forecast period. Furthermore, wide applications of the technique, painless diagnosis and in-depth analysis results in increasing the market. In most of the developing and under-developed countries, less popularity of the technique and high cost is the restraining factor for the market to grow in. The harmful effects of the radiations also hinders the growth in the diagnosis services market. Lack of skilled personnel for carrying out the diagnostic practices using radionuclide tracers is also a limiting factor in the market growth.

A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/16639

Radionuclide Scanning Services Market: Segmentation

By Visualization Type:

Heart blood flow and functions
Differential lung function
Body Infections & inflammations
Bone fracture & infections
Gall Bladder & Bile Duct Functions
Gastrointestinal bleeding
Tumor Localization
Others
By Applications

Diagnosis
Prognosis
By Distribution Channels

Hospitals
Clinics
Diagnostic Centers
By Geography

North America
Europe
Latin America
Asia-Pacific
Middle East and Africa

Large number of players in the market increases the competition. R&D activities, continuous innovation and improvisation of the technique also helps in moving the market ahead. Providing safe, cost effective and reliable services is the demand in the market. The brand name of various service providers are attracting the business. Various marketing strategies are adopted by the service providers to lure the doctors and patients for the services.

Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/16639

A geographic condition regarding the radionuclide scanning services market, it has been segmented into five key regions: North America, Latin America, Europe, Asia-Pacific and Middle East & Africa. North America holds the largest market share in the radionuclide scanning services due to large number of service providers in the region, good reimbursement scenario and health facilities in the reach of most of the population. This is followed by Europe because of better healthcare infrastructure and large number of government funded hospitals and laboratories. Asia-Pacific is still considered to be the growing segment because of increasing number of service providers in the region, but does not meet the high population density in the region.

The radionuclide service providers includes the hospitals and private laboratories. Some of the key players in the radionuclide scanning services market include Sonic Healthcare, Aditya Birla Health Services Ltd., Cleveland Clinic, The London Clinic, The GEL Group, Inc., Alliance Medical, Global Diagnostics and many others.

To view complete report @ http://www.persistencemarketresearch.com/market-research/radionuclide-scanning-services-market.asp

About Us 
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
 PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
media@persistencemarketresearch.com
Web:www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Radionuclide Scanning Services Market is Expected to Witness a Steady Growth by 2017 – 2025 here

News-ID: 618308 • Views:

More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Persistence Market Research
Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by Sustainability and Supply Chain Efficiency
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Growth - Persistence Market Research
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Healthcare Demand
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained

All 5 Releases


More Releases for Radionuclide

Radionuclide Drug Conjugates (RDCs) Market Growth Set to Surge Significantly by …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radionuclide Drug Conjugates (RDCs) Market Size, Share & Trends Analysis Report By Type (Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)), Disease Indication (Neuroendocrine Tumors, Prostate Cancer, Renal Cell, Carcinoma, Others)- Market Outlook And Industry Analysis 2031" The Global Radionuclide Drug Conjugates (RDCs) Market is expected to grow with a CAGR
Radionuclide Therapy Equipment Market Size And Global Industry Forecast 2034
" In 2024, the global radionuclide therapy equipment market is valued at approximately $4.3 billion, driven by increasing prevalence of cancer and advancements in targeted therapies. The market is projected to reach around $7.8 billion by 2034, reflecting significant growth opportunities primarily attributed to technological advancements, enhanced diagnostic capabilities, and a rising focus on personalized medicine. " Exactitude Consultancy., Ltd. released a research report titled "Radionuclide Therapy Equipment Market". This report
Antibody-radionuclide Conjugates Market Share Research Report 2025
On Mar 6, 2025, Global Info Research released a research report titled "Global Antibody-radionuclide Conjugates Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides detailed data analysis of the Antibody-radionuclide Conjugates market from 2020 to 2031. Including the market size and development trends of Antibody-radionuclide Conjugates Market, it analyzes market size indicators such as sales, sales volume, average price and CAGR, it also provides a
Radionuclide Drug Conjugates (RDCs) Market Robust Expansion is expected to 2031
Radionuclide Drug Conjugates (RDCs) Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radionuclide Drug Conjugates (RDCs) Market Size, Share & Trends Analysis Report By Type (Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)), Disease Indication (Neuroendocrine Tumors, Prostate Cancer, Renal Cell, Carcinoma, Others)- Market Outlook
Radionuclide Drug Conjugates (RDC) Market Minimizing Side Effects, Maximizing Im …
Radionuclide Drug Conjugates (RDCs) Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radionuclide Drug Conjugates (RDCs) Market Size, Share & Trends Analysis Report By Type (Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)), Disease Indication (Neuroendocrine Tumors, Prostate Cancer, Renal Cell, Carcinoma, Others)- Market Outlook
Peptide Receptor Radionuclide Therapy Market Analysis, Size, Current Scenario an …
Peptide Receptor Radionuclide Therapy Market is anticipated to grow at a significant CAGR during the forecast period. The increasing prevalence of neuroendocrine tumors is expected to impel the demand for peptide receptor radionuclide therapy (PRRT) as an increasing number of the patient pool. The establishment of reimbursement policies for Lutathera favors the demand for peptide receptor radionuclide therapy (PRRT). Moreover, increasing clinical trials for the new radiopharmaceuticals drugs approval for cancer